Digital therapeutics (DTx) deliver medical interventions directly to patients using evidence-based, clinically evaluated software to treat, manage, and prevent a broad spectrum of diseases and disorders. DTx products are held to the same standards of evidence and regulatory oversight as traditional medical treatments. DTx products can address critical gaps in care for underserved populations, regardless of patient age, language, culture, income, disease state, or geography.
Digital therapeutics improve patient outcomes for a wide range of diseases and disorders with clinically proven technologies accessible through devices such as smartphones or personal tablets.
DTx products may expand access to proven therapies, offer treatment options for un- or undertreated conditions, and empower patients with self-management tools. They are used independently or in concert with medications, devices, or other therapies to optimize patient care and health outcomes.